(ANA), also known
as N-arachidonoylethanolamine (AEA), is a fatty
acid neurotransmitter. Anandamide
was the first endocannabinoid
to be discovered:...
- and are the main molecular target
of the endogenous partial
(AEA), as well as exogenous
THC, the most known active component
- Delta-8-Tetrahydrocannabinol (Δ8-THC), through intracellular
CB1 activation, induce anandamide
and 2-arachidonoylglycerol synthesis produced naturally
in the body and...
- hydrolase, anandamide
amidohydrolase) is a member
of the serine hydrolase family
of enzymes. It was first shown
in 1993. In...
- endocannabinoids, a group
of retrograde neurotransmitters
that include anandamide
and 2-arachidonoylglycerol (2-AG); plant
phytocannabinoids, such as the...
(DAG). 2-AG, unlike anandamide
(another endocannabinoid), is present
than other phases
of the cycle. Another
is the endocannabinoid anandamide
the lowest plasma
in the luteal
- 2-arachidonoylglycerol (2-AG) and anandamide
at comparable rates
in vitro, genetic
or pharmacological disruption
of FAAH elevates anandamide
but not 2-AG, suggesting...
- William Anthony Devane isolated
and first described
, an endogenous cannabinoid
neurotransmitter. Lumír Hanuš was born in 1947...
- for the isolation
and the identification
of the endogenous cannabinoids anandamide
from the brain
and 2-arachidonoyl glycerol
(2-AG) from peripheral